Terms: = Ovarian cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
18 results:
1. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
2. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
3. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
4. One-stop molecular classification of endometrial carcinoma using comprehensive next-generation sequencing.
Li Y; Chen R; Yuan M; Wang D; Fu C; Chen R; Lei C; Zhou Q
Int J Cancer; 2022 Dec; 151(11):1969-1977. PubMed ID: 36036365
[TBL] [Abstract] [Full Text] [Related]
5. lncRNA SNHG15 Promotes ovarian cancer Progression through Regulated cdk6 via Sponging miR-370-3p.
Wang Y; Ding M; Yuan X; Jiao R; Zhu D; Huang W; Deng W; Liu Y
Biomed Res Int; 2021; 2021():9394563. PubMed ID: 34734088
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
[TBL] [Abstract] [Full Text] [Related]
7. Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.
Li Y; Lin S; An N
Cell Cycle; 2020 Aug; 19(15):1857-1868. PubMed ID: 32588730
[TBL] [Abstract] [Full Text] [Related]
8. Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study.
Korach J; Colombo N; Mendiola C; Selle F; Dolado I; Donica M; Oza AM
J Surg Oncol; 2019 Sep; 120(4):786-793. PubMed ID: 31368160
[TBL] [Abstract] [Full Text] [Related]
9. Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed ovarian cancer in the International ROSiA Study.
Selle F; Colombo N; Korach J; Mendiola C; Cardona A; Ghazi Y; Oza AM
Int J Gynecol Cancer; 2018 May; 28(4):729-737. PubMed ID: 29498983
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract] [Full Text] [Related]
11. [Expression of cdk6 in early ovarian cancer and its clinical significance].
Ling C; Liu S; Wang Y; Zhang FC; Du Y
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1271-1275. PubMed ID: 27687663
[TBL] [Abstract] [Full Text] [Related]
12. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract] [Full Text] [Related]
13. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
[TBL] [Abstract] [Full Text] [Related]
14. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract] [Full Text] [Related]
15. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
[TBL] [Abstract] [Full Text] [Related]
16. [Expression and significance of tumor suppressor gene WAF1 in epithelial ovarian neoplasms].
Cao L; Yang Z; Li X
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):602-4. PubMed ID: 10806783
[TBL] [Abstract] [Full Text] [Related]
17. Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125.
Rella C; Coviello M; De Frenza N; Falco G; Chiuri E; Colavito P; Quaranata M; De Leonardis A
Tumori; 1993 Oct; 79(5):347-51. PubMed ID: 8116080
[TBL] [Abstract] [Full Text] [Related]
18. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract] [Full Text] [Related]
